Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED concludes successfully its £203 million take-private bid for drug development software leader Instem

ARCHIMED concludes successfully its £203 million take-private bid for drug development software leader Instem

ARCHIMED expands neurodiagnostic business in Europe and the US

 September

 23, 

2019

Bomi Group further expands in LATAM and completes the acquisition of ILS Corporation in Ecuador and Peru

 August

 14, 

2019

ARCHIMED leads the management buyout of EUROLyser, a specialist in innovative Point-of-Care Testing

 July

 9, 

2019

Flash News – RehabWorks rebranded as of 1st of July 2019

 July

 8, 

2019

Italian dental clinics network Primo goes digital

 June

 6, 

2019

ARCHIMED acquires In Vitro Diagnostics specialist in cross-border carve-out

 May

 22, 

2019

< 1 … 9 10 11 12 13 … 15 >
368
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top